Johan Askling

30.6k total citations · 4 hit papers
411 papers, 18.8k citations indexed

About

Johan Askling is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Johan Askling has authored 411 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Rheumatology, 93 papers in Pathology and Forensic Medicine and 70 papers in Genetics. Recurrent topics in Johan Askling's work include Rheumatoid Arthritis Research and Therapies (195 papers), Lymphoma Diagnosis and Treatment (72 papers) and Systemic Lupus Erythematosus Research (71 papers). Johan Askling is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (195 papers), Lymphoma Diagnosis and Treatment (72 papers) and Systemic Lupus Erythematosus Research (71 papers). Johan Askling collaborates with scholars based in Sweden, United States and United Kingdom. Johan Askling's co-authors include Lars Klareskog, Eva Baecklund, L. Jacobsson, Martin Neovius, Anders Ekbom, Anders Ekbom, Jonas F. Ludvigsson, Thomas Frisell, Nils Feltelius and Julia F. Simard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Johan Askling

387 papers receiving 18.4k citations

Hit Papers

Association of chronic in... 2006 2026 2012 2019 2006 2009 2020 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
    2006 667 citations Eva Baecklund, Johan Askling et al. profile →
  2. Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
    2009 604 citations Johan Askling et al. profile →
  3. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
    2020 321 citations Ola Olén, Rune Erichsen et al. profile →
  4. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
    2021 169 citations Jonas F. Ludvigsson, Johan Askling et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Johan Askling 8.0k 4.3k 3.5k 3.2k 2.9k 411 18.8k
Manuel Ramos‐Casals 7.8k 1.0× 2.6k 0.6× 2.1k 0.6× 4.2k 1.3× 2.0k 0.7× 258 18.2k
Jean Sibilia 6.8k 0.9× 2.2k 0.5× 3.5k 1.0× 4.1k 1.3× 1.3k 0.4× 460 16.8k
Xavier Mariette 7.3k 0.9× 1.7k 0.4× 2.4k 0.7× 4.7k 1.5× 2.1k 0.7× 452 19.6k
P. Cacoub 8.8k 1.1× 10.1k 2.3× 3.2k 0.9× 4.0k 1.2× 1.2k 0.4× 754 32.3k
Eric L. Matteson 12.4k 1.6× 2.9k 0.7× 3.2k 0.9× 4.0k 1.3× 1.1k 0.4× 465 25.5k
Miguel Á. González‐Gay 13.5k 1.7× 2.9k 0.7× 2.3k 0.7× 6.3k 2.0× 1.2k 0.4× 799 25.0k
Stefano Bombardieri 6.4k 0.8× 1.8k 0.4× 2.8k 0.8× 5.1k 1.6× 1.2k 0.4× 448 16.2k
Andrea Doria 10.3k 1.3× 3.1k 0.7× 2.6k 0.7× 7.0k 2.2× 1.2k 0.4× 515 17.9k
Zahir Amoura 7.3k 0.9× 1.8k 0.4× 1.8k 0.5× 6.3k 1.9× 802 0.3× 424 17.6k
Pier Luigi Meroni 18.0k 2.3× 2.3k 0.5× 3.0k 0.9× 9.0k 2.8× 3.1k 1.1× 621 28.6k

Countries citing papers authored by Johan Askling

Since Specialization
Citations

This map shows the geographic impact of Johan Askling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Askling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Askling more than expected).

Fields of papers citing papers by Johan Askling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Askling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Askling. The network helps show where Johan Askling may publish in the future.

Co-authorship network of co-authors of Johan Askling

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Askling. A scholar is included among the top collaborators of Johan Askling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Askling. Johan Askling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Erpeng, Benjamin Hon Kei Yip, Arad Kodesh, et al.. (2025). Maternal rheumatoid arthritis and the risk of offspring autism spectrum disorder: two national birth cohorts and a meta-analysis. Molecular Autism. 16(1). 61–61.
2.
3.
4.
Exarchou, Sofia, Daniela Di Giuseppe, Eva Klingberg, et al.. (2023). Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the Rheumatic Diseases. 83(4). 446–456. 9 indexed citations
5.
Sjölander, Arvid, et al.. (2023). Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application. Lara D. Veeken. 62(10). 3391–3399. 8 indexed citations
6.
Delcoigne, Bénédicte, et al.. (2023). Disease‐modifying antirheumatic drugs and risk of thyroxine‐treated autoimmune thyroid disease in patients with rheumatoid arthritis. Journal of Internal Medicine. 295(3). 313–321. 5 indexed citations
7.
Bergman, David, Björn Roelstraete, Jiangwei Sun, et al.. (2023). Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population‐based matched cohort study. Alimentary Pharmacology & Therapeutics. 58(10). 1028–1040. 2 indexed citations
8.
Saevarsdóttir, Saedís, Lina-Marcela Díaz-Gallo, Lars Alfredsson, et al.. (2023). Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis. Lara D. Veeken. 63(5). 1221–1229. 1 indexed citations
9.
Exarchou, Sofia, Johan K. Wallman, Daniela Di Giuseppe, et al.. (2023). The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017. The Journal of Rheumatology. 50(6). 781–788. 2 indexed citations
10.
Glintborg, Bente, Daniela Di Giuseppe, Johan K. Wallman, et al.. (2023). Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the Rheumatic Diseases. 82(6). 820–828. 14 indexed citations
11.
Hedberg, Pontus, Fredrik Granath, Judith Bruchfeld, et al.. (2022). Post COVID‐19 condition diagnosis: A population‐based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. Journal of Internal Medicine. 293(2). 246–258. 41 indexed citations
12.
Rossides, Marios, Susanna Kullberg, Daniela Di Giuseppe, et al.. (2021). Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data. Respirology. 26(5). 452–460. 24 indexed citations
13.
Hellgren, Karin, Daniela Di Giuseppe, Karin E. Smedby, et al.. (2020). Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs—a Swedish cohort study of risks by time, drug and lymphoma subtype. Lara D. Veeken. 60(2). 809–819. 27 indexed citations
14.
Axelrad, Jordan E., Ola Olén, Michael C. Sachs, et al.. (2020). Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut. 70(2). 297–308. 36 indexed citations
15.
Hellgren, Karin, Christine Ballegaard, Bénédicte Delcoigne, et al.. (2020). Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study. Lara D. Veeken. 60(8). 3656–3668. 9 indexed citations
16.
Lindström, Ulf, Bente Glintborg, Daniela Di Giuseppe, et al.. (2020). Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Lara D. Veeken. 60(8). 3635–3645. 18 indexed citations
17.
Glintborg, Bente, Ulf Lindström, Daniela Di Giuseppe, et al.. (2020). One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses. Arthritis Care & Research. 74(5). 748–758. 15 indexed citations
18.
Malmborg, Petter, Michael C. Sachs, Johan Askling, et al.. (2020). Adult height in patients with childhood‐onset inflammatory bowel disease: a nationwide population‐based cohort study. Alimentary Pharmacology & Therapeutics. 51(8). 789–800. 15 indexed citations
19.
Ehlers, Lisa, Johan Askling, Maurizio Cutolo, et al.. (2019). 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Annals of the Rheumatic Diseases. 78(9). 1160–1166. 57 indexed citations
20.
Rossides, Marios, Johan Grünewald, Anders Eklúnd, et al.. (2018). Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study. European Respiratory Journal. 52(2). 1800385–1800385. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Ramos‐Casals Breakdown of academic impact, for papers by Jean Sibilia Breakdown of academic impact, for papers by Xavier Mariette Breakdown of academic impact, for papers by P. Cacoub Breakdown of academic impact, for papers by Eric L. Matteson Breakdown of academic impact, for papers by Miguel Á. González‐Gay Breakdown of academic impact, for papers by Stefano Bombardieri Breakdown of academic impact, for papers by Andrea Doria Breakdown of academic impact, for papers by Zahir Amoura Breakdown of academic impact, for papers by Pier Luigi Meroni
Rankless by CCL
2026